George B. Rathmann

George B. Rathmann

Keine laufenden Positionen mehr

Health Technology
Commercial Services
Consumer Services

Ursprung des Netzwerks ersten Grades von George B. Rathmann

EinheitArt der EinheitIndustrie
Nuvelo, Inc.
26
Extinct Pharmaceuticals: Major 26
17
Subsidiary Pharmaceuticals: Other 17

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von George B. Rathmann

UnternehmenSektorVerknüpfte PersonenHauptposition
ABBOTT LABORATORIES Medical Specialties

David Milligan

Paul Clark

Mark P. Joing

Chief Tech/Sci/R&D Officer

Director/Board Member

Corporate Officer/Principal

Biotechnology

Ted Love

Linda Fitzpatrick

Kim Popovits

Luis Peña

Kirk James Hayenga

General Counsel

Investor Relations Contact

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

Mark Perry

Ted Love

Linda Fitzpatrick

Simon Allen

Director of Finance/CFO

Director/Board Member

Public Communications Contact

Corporate Officer/Principal

Biotechnology

Christopher Henney

Mark Lupher

Founder

Corporate Officer/Principal

LINEAGE CELL THERAPEUTICS, INC. Biotechnology

Peter García

Walter Funk

Director of Finance/CFO

Corporate Officer/Principal

COMBIMATRIX CORP Biotechnology

Elias Bendekgey

Shelly Guyer

Corporate Secretary

Director of Finance/CFO

Pharmaceuticals: Major

Paul Clark

Kenneth Ferguson

Chief Executive Officer

Chief Tech/Sci/R&D Officer

OMEROS CORPORATION Pharmaceuticals: Major

Leonard M. Blum

J. Whitaker

Albert S. Yu

Kenneth Ferguson

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

Ted Love

Linda Fitzpatrick

Chairman

Chairman

SUTRO BIOPHARMA, INC. Pharmaceuticals: Major

Linda Fitzpatrick

Mark Lupher

Public Communications Contact

Corporate Officer/Principal

Pharmaceuticals: Major

W. Michael Gallatin

Clifford Stocks

Albert S. Yu

Founder

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

INVITAE CORPORATION Medical/Nursing Services

Elias Bendekgey

Shelly Guyer

General Counsel

Director of Finance/CFO

MYOKARDIA, INC. Pharmaceuticals: Major

Mark Perry

Kim Popovits

Director/Board Member

Director/Board Member

College/University

Burton E. Sobel

Mark Lupher

Doctorate Degree

Doctorate Degree

Stanford University College/University

Peter García

Leonard M. Blum

Mark P. Joing

Undergraduate Degree

Masters Business Admin

Masters Business Admin

College/University

Jeffrey G. Hesselberg

Christopher Henney

Burton E. Sobel

Mark Lupher

J. Whitaker

Albert S. Yu

Masters Business Admin

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

Graduate Degree

Doctorate Degree

Emory University College/University

James R. Gavin

Corporate Officer/Principal

University of California, Los Angeles College/University

Gary L. Wilcox

Peter García

Corporate Officer/Principal

Masters Business Admin

INNOVIVA, INC. Pharmaceuticals: Major

Ted Love

Leonard M. Blum

Luis Peña

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Steven R. Deitcher

S. Michael Imperiale

Chief Executive Officer

Chief Tech/Sci/R&D Officer

College/University

Mary K. Pendergast

Steven R. Deitcher

Mark P. Joing

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Haverford College College/University

Barry Zubrow

Ted Love

Corporate Officer/Principal

Undergraduate Degree

Livingstone College College/University

James R. Gavin

Undergraduate Degree

College/University

Burton E. Sobel

Kenneth Ferguson

Undergraduate Degree

Undergraduate Degree

Investment Trusts/Mutual Funds

James R. Gavin

Chief Tech/Sci/R&D Officer

Princeton University College/University

David Milligan

Thomas N. McCarter

Leonard M. Blum

Shelly Guyer

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

San Francisco State University College/University

Linda Fitzpatrick

Luis Peña

Undergraduate Degree

Undergraduate Degree

University of Wisconsin College/University

Jeffrey G. Hesselberg

Mark E. Gitter

Undergraduate Degree

Masters Business Admin

University of California, Berkeley College/University

Mark Perry

David M. Rosen

Undergraduate Degree

Doctorate Degree

CYCLACEL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Christopher Henney

Kenneth Ferguson

Chairman

Director/Board Member

Medical/Nursing Services

James R. Gavin

Chief Executive Officer

Morehouse School of Medicine College/University

James R. Gavin

President

Investment Managers

David McElligott

Kenneth Ferguson

Corporate Officer/Principal

Private Equity Investor

National Charity League, Inc.

Linda Fitzpatrick

Corporate Officer/Principal

Coyote Point Museum

Linda Fitzpatrick

Director/Board Member

Hillsborough Schools Foundation

Linda Fitzpatrick

President

ARCA BIOPHARMA, INC. Pharmaceuticals: Major

Burton E. Sobel

Ted Love

Mary K. Pendergast

Director/Board Member

Director/Board Member

Director/Board Member

The Indiana University School of Medicine College/University

James R. Gavin

J. Whitaker

Corporate Officer/Principal

Doctorate Degree

Duke University School of Medicine College/University

James R. Gavin

Doctorate Degree

San Mateo Public Library Foundation

Linda Fitzpatrick

President

A Home Within

Linda Fitzpatrick

Director/Board Member

GLOBAL BLOOD THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Perry

Ted Love

Chairman

Chief Executive Officer

Curiodyssey

Linda Fitzpatrick

Director/Board Member

Statistik

International

Vereinigte Staaten 50
Kanada 2

Sektoral

Health Technology 23
Consumer Services 17
Finance 3
Health Services 3
Commercial Services 2

Operativ

Director/Board Member 191
Corporate Officer/Principal 114
Independent Dir/Board Member 51
Undergraduate Degree 42
Chief Tech/Sci/R&D Officer 39
  1. Börse
  2. Insiders
  3. George B. Rathmann
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT